Neurowyzr, a Singapore-based health tech company that specializes in brain health, has raised an additional US$2.1 million in seed funding. The round was led by Jungle Ventures and Peak XV's Surge, with participation from various angel investors. The company intends to use the funds to accelerate product development and expand into new markets in Southeast Asia and India.
Neurowyzr was founded in 2019 by Nav Vij and Pang Sze Yunn. The company's first product is an online gamified digital neuroscience assessment called the Digital Brain Function Screen (DBFS). The DBFS is a quick and easy way to assess brain health and identify potential problems. The DBFS is already available in a growing number of health screening centres, GP clinics, and specialist centres in Singapore. It has also been piloted in India and has been registered with the U.S. Food and Drug Administration.
With this new funding, Neurowyzr is well-positioned to continue its growth and make a significant impact on brain health around the world.
